These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9703909)

  • 1. Antitumor effects of erucylphosphocholine on brain tumor cells in vitro and in vivo.
    Erdlenbruch B; Jendrossek V; Marx M; Hunold A; Eibl H; Lakomek M
    Anticancer Res; 1998; 18(4A):2551-7. PubMed ID: 9703909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of alkylphosphocholine derivatives: antineoplastic action on brain tumor cell lines in vitro.
    Jendrossek V; Hammersen K; Erdlenbruch B; Kugler W; Krügener R; Eibl H; Lakomek M
    Cancer Chemother Pharmacol; 2002 Jul; 50(1):71-9. PubMed ID: 12111115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats.
    Erdlenbruch B; Jendrossek V; Kugler W; Eibl H; Lakomek M
    Cancer Chemother Pharmacol; 2002 Oct; 50(4):299-304. PubMed ID: 12357304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAP kinase pathways involved in glioblastoma response to erucylphosphocholine.
    Kugler W; Erdlenbruch B; Otten K; Jendrossek V; Eibl H; Lakomek M
    Int J Oncol; 2004 Dec; 25(6):1721-7. PubMed ID: 15547710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of differentiation and tetraploidy by long-term treatment of C6 rat glioma cells with erucylphosphocholine.
    Jendrossek V; Kugler W; Erdlenbruch B; Eibl H; Lakomek M
    Int J Oncol; 2001 Oct; 19(4):673-80. PubMed ID: 11562740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erucylphosphocholine, a novel antineoplastic ether lipid, blocks growth and induces apoptosis in brain tumor cell lines in vitro.
    Jendrossek V; Erdlenbruch B; Hunold A; Kugler W; Eibl H; Lakomek M
    Int J Oncol; 1999 Jan; 14(1):15-22. PubMed ID: 9863004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of Apaf-1 and caspase-3 by RNA interference in human glioma cells: consequences for erucylphosphocholine-induced apoptosis.
    Kugler W; Buchholz F; Köhler F; Eibl H; Lakomek M; Erdlenbruch B
    Apoptosis; 2005 Oct; 10(5):1163-74. PubMed ID: 16151649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of in vitro and in vivo effect of docosahexaenoic acid on rat C6 glioma.
    Nasrollahzadeh J; Siassi F; Doosti M; Eshraghian MR
    J Exp Ther Oncol; 2009; 8(2):95-103. PubMed ID: 20192116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erucylphosphocholine: pharmacokinetics, biodistribution and CNS-accumulation in the rat after intravenous administration.
    Erdlenbruch B; Jendrossek V; Gerriets A; Vetterlein F; Eibl H; Lakomek M
    Cancer Chemother Pharmacol; 1999; 44(6):484-90. PubMed ID: 10550569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model.
    Kaiser MG; Parsa AT; Fine RL; Hall JS; Chakrabarti I; Bruce JN
    Neurosurgery; 2000 Dec; 47(6):1391-8; discussion 1398-9. PubMed ID: 11126910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase antisense oligodeoxynucleotides as a novel therapeutic agent for malignant glioma: in vitro and in vivo studies of uptake, effects and toxicity.
    Engelhard H; Narang C; Homer R; Duncan H
    Biochem Biophys Res Commun; 1996 Oct; 227(2):400-5. PubMed ID: 8878527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic effect of 125IUdR on the glioma cell line C6 in vitro and in vivo].
    Wu B; You C; Liu XD; Cai BW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):671-4. PubMed ID: 15460416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid inhibits proliferation and changes expression of CD44 and CD56 of malignant glioma cells in vitro.
    Knüpfer MM; Hernáiz-Driever P; Poppenborg H; Wolff JE; Cinatl J
    Anticancer Res; 1998; 18(5A):3585-9. PubMed ID: 9858943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erucylphosphocholine-induced apoptosis in glioma cells: involvement of death receptor signalling and caspase activation.
    Kugler W; Erdlenbruch B; Jünemann A; Heinemann D; Eibl H; Lakomek M
    J Neurochem; 2002 Sep; 82(5):1160-70. PubMed ID: 12358763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of taurolidine on brain tumor cells.
    Stendel R; Stoltenburg-Didinger G; Al Keikh CL; Wattrodt M; Brock M
    Anticancer Res; 2002; 22(2A):809-14. PubMed ID: 12014655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
    Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
    Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity study of erucylphosphocholine in a rat model.
    Schuettauf F; Eibl KH; Thaler S; Shinoda K; Rejdak R; May CA; Blatsios G; Welge-Lussen U
    Curr Eye Res; 2005 Sep; 30(9):813-20. PubMed ID: 16146926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human T98G glioblastoma multiforme xenografts.
    Teicher BA; Menon K; Alvarez E; Galbreath E; Shih C; Faul M
    Clin Cancer Res; 2001 Mar; 7(3):634-40. PubMed ID: 11297259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
    Price A; Shi Q; Morris D; Wilcox ME; Brasher PM; Rewcastle NB; Shalinsky D; Zou H; Appelt K; Johnston RN; Yong VW; Edwards D; Forsyth P
    Clin Cancer Res; 1999 Apr; 5(4):845-54. PubMed ID: 10213221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
    Grommes C; Landreth GE; Sastre M; Beck M; Feinstein DL; Jacobs AH; Schlegel U; Heneka MT
    Mol Pharmacol; 2006 Nov; 70(5):1524-33. PubMed ID: 16887936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.